Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization (Q30432136)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

based on heuristic

inferred from title

7

object named as

Dimmock NJ

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Durrani Z

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

McInerney TL

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

McLain L

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jones T

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Bellaby T

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Brennan FR

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 1998

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

220

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

93-103

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

The expression of hybrid HIV:Ty virus-like particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Nasal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Cellular immune factors associated with mother-to-infant transmission of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Plant-derived vaccine protects target animals against a viral disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Genetic vaccination: the advantages of going naked

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Expression of an Animal Virus Antigenic Site on the Surface of a Plant Virus Particle

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-1759(98)00145-8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30432136&oldid=2107489389"